C. Perriotte‐Olson

Hematopoietic cyclooxygenase‐2 deficiency increases adipose tissue inflammation and adiposity in obesity

V. Saraswathi, Ramesh Ramalingam, Nikhil Adi, 2015, Obesity.

Nanoformulated SOD1 Ameliorates the Combined NASH and Alcohol-Associated Liver Disease Partly via Regulating CYP2E1 Expression in Adipose Tissue and Liver.

E. Harris, V. Saraswathi, A. Kabanov, 2020, American journal of physiology. Gastrointestinal and liver physiology.

Nanoformulated copper/zinc superoxide dismutase attenuates vascular cell activation and aortic inflammation in obesity.

V. Saraswathi, A. Kabanov, D. Manickam, 2016, Biochemical and biophysical research communications.

Effect of nanoformulated copper/zinc superoxide dismutase on chronic ethanol-induced alterations in liver and adipose tissue.

E. Harris, V. Saraswathi, A. Kabanov, 2019, Alcohol.

A combination of dietary N-3 fatty acids and a cyclooxygenase-1 inhibitor attenuates nonalcoholic fatty liver disease in mice.

V. Saraswathi, M. Ganesan, C. Desouza, 2017, The Journal of nutritional biochemistry.

Nanoformulated copper/zinc superoxide dismutase exerts differential effects on glucose vs lipid homeostasis depending on the diet composition possibly via altered AMPK signaling

R. Powers, V. Saraswathi, A. Kabanov, 2017, Translational research : the journal of laboratory and clinical medicine.

Effects of leptin replacement alone and with exendin-4 on food intake and weight regain in weight-reduced diet-induced obese rats.

P. Chelikani, R. Reidelberger, J. Blevins, 2012, American journal of physiology. Endocrinology and metabolism.

Effect of nanoformulated copper/zinc superoxide dismutase on chronic ethanol-induced alterations in liver and adipose tissue.

E. Harris, V. Saraswathi, A. Kabanov, 2019, Alcohol.

Nanoformulated copper/zinc superoxide dismutase reduces adipose inflammation in obesity

V. Saraswathi, A. Kabanov, D. Manickam, 2016, Obesity.